Results 31 to 40 of about 2,792,307 (313)
Pediatrics & Neonatology, 2018 Neonatal tumors are different from tumors of the older children and knowledge gained from treating older children can not be extrapolated to neonates. Neonates have immature physiology and their haematopoietic and immune systems are not fully developed and the response to therapy is unpredictable.
openaire +3 more sources
Role of Bcl-3 in solid tumors [PDF]
, 2011 Bcl-3 is an established oncogene in hematologic malignancies, such as B-cell chronic lymphocytic leukemias. Nevertheless, recent research has shown that it also participates in progression of diverse solid tumors.
Vilma Maldonado +3 more
core +1 more source
Tumor–platelet interaction in solid tumors [PDF]
International Journal of Cancer, 2012 AbstractElevated platelet counts in patients diagnosed with malignant tumors were first described more than 100 years ago. Today it is well known that in many types of solid tumors, thrombocytosis at the time of diagnosis is associated with shorter survival.
Daniel, Buergy +3 more
openaire +2 more sources
Nature Communications, 2023 Drug combinations are key to circumvent resistance mechanisms compromising response to single anti-cancer targeted therapies. The implementation of combinatorial approaches involving MEK1/2 or KRASG12C inhibitors in the context of KRAS-mutated lung ...
Irati Macaya +31 more
doaj +1 more source
Test schemes covered under MPQAP EQAS program for solid tumors.
, 2022 Test schemes covered under MPQAP EQAS program for solid tumors.
Ramya Iyer (13844211) +9 more
core +1 more source
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
npj Breast Cancer, 2021 Novel antibody-drug conjugates against HER2 are showing high activity in HER2-negative breast cancer (BC) with low HER2 expression (i.e., 1+ or 2+ and lack of ERBB2 amplification). However, the clinical and molecular features of HER2-low BC are yet to be
Francesco Schettini +26 more
doaj +1 more source
FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
Journal of Translational MedicineBackground Acute pancreatitis (AP) presents a significant clinical challenge with limited therapeutic options. The complex etiology and pathophysiology of AP emphasize the need for innovative treatments.
Amaya Lopez-Pascual +18 more
doaj +1 more source
Molecular Oncology, 2020 Development of precision medicine for malignant pleural mesothelioma (MPM) requires a deep knowledge of tumor heterogeneity. Histologic and molecular classifications and histo‐molecular gradients have been proposed to describe heterogeneity, but a deeper
Lisa Quetel +20 more
doaj +1 more source
, 2007 Uniform DNA distribution in tumors is a prerequisite step for high transfection efficiency in solid tumors. To improve the transfection efficiency of electrically assisted gene delivery to solid tumors in vivo, we explored how tumor histological ...
Grosel, A. +7 more
core +1 more source
The interplay between stress and growth in solid tumors [PDF]
, 2012 A number of biological phenomena are interlaced with classical mechanics. In this review we discuss the role of mechanics in tumor growth, namely the avascular phase of solid tumors.
Ambrosi, Davide Carlo +4 more
core +1 more source